Bio Preventive Medicine Corp. Ltd. of Zhubei City, Hsinchu at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Bio Preventive Medicine Corp. Ltd.

6f-1, No. 18 Taiyuan St., 30265 Zhubei City, Hsinchu
Telephone +886 3 5601816
Fax +886 3 5601916

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
TAITRA Taiwan External Trade Development Council

Hall map

MEDICA 2021 hall map (Hall 16): stand C36

Fairground map

MEDICA 2021 fairground map: Hall 16


Howie Yiu

Sales & Marketing

+886 3 5601816


Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Our products

Product category: Immuno assay testing

uPTM3-DKD (DNlite-IVD103) ELISA Test: Novel Tool for Precision Management of Diabetic Kidney Disease (DKD)

uPTM3-DKD (DNlite-IVD103)  is a urinary ELISA kit that precisely manages Diabetic Kidney Disease (DKD). By detecting a specific urinary biomarker and meticulously monitoring for post translational modifications to the marker, DNlite-IVD103 can effectively predict the kidney condition of a diabetes patient over the 1-2 years that follow. If a risk of progressive Glomerular Filtration Rate (GFR) decline is detected, patients can be recommended to start proper treatment earlier, and seize a critical window for clinical action and even recovery. Prediction of decline or kidney complications will drastically improve the DKD patient’s quality of care. DNlite-IVD103 has obtained CE IVD mark, Malaysia MDA and other regulatory-approvals for global market. BPM is seeking worldwide distribution partner for DNlite-IVD103. For more information, please refer to BPM official website: 

More Less

About us

Company portrait

Bio Preventive Medicine Corporation (BPM) is a leading company in renal biomarker area and has focused on translating validated and IP-protected biomarkers into diagnostic solutions for unmet clinical needs, especially among the fields of disease’s early detection and prevention in diabetes related complications, such as Diabetic Kidney Disease (DKD), Chronic Kidney Disease (CKD) and kidney injury.

Our expertise in DKD and non-proteinuric renal disease led to the development of breakthrough IVD product, CE IVD marked uPTM3-DKD (DNlite-IVD103) ELISA test, which detects a unique post translational modification of a DKD biomarker and identified by large urinary proteomic studies. DNlite-IVD103 is a non-invasive urinary test for effectively predicting/ monitoring the progression of DKD over the 1-2 years that follow.

We are open for any collaboration opportunities. For more information, please visit:

Company data

Area of business Diagnostic tests

Company information as a PDF file